CATHFLO

Product Overview

About CATHFLO

CATHFLO is a prescription medication containing the active ingredient ALTEPLASE, a recombinant tissue plasminogen activator (rt-PA). It is used for the treatment of acute ischemic stroke within 3-4.5 hours after symptom onset.

Key Benefits & Uses

• Treatment of acute ischemic stroke within 3-4.5 hours after symptom onset.
• Thrombolytic agent to dissolve blood clots in the brain.
• Improves neurological outcomes and reduces disability in stroke patients.

Active Ingredient & Action

ALTEPLASE works by activating plasminogen to plasmin, which then breaks down blood clots. This process helps to restore blood flow to the affected area of the brain, reducing the risk of further damage and improving neurological outcomes.

Important Notes

CATHFLO should only be used under the guidance of a healthcare professional. It is essential to carefully evaluate the patient's medical history, including any bleeding disorders or recent surgeries, before administering the medication. Monitor patients for signs of bleeding, such as bruising, petechiae, or hematuria, and adjust treatment accordingly.